Biontech investor calendar

WebFeb 4, 2024 · BioNTech’s largest shareholders are biotech investors Thomas and Andreas Struengmann, who hold about half of the company’s shares between them. ($1 = 0.8341 … WebFinancial Calendar BioNTech - investors.biontech.de

What 12 Analyst Ratings Have To Say About BioNTech

WebApr 11, 2024 · 13 analysts have issued twelve-month price targets for BioNTech's shares. Their BNTX share price forecasts range from $130.00 to $260.00. On average, they anticipate the company's share price to reach $178.50 in the next twelve months. This suggests a possible upside of 38.5% from the stock's current price. WebApr 10, 2024 · BIONTECH SE company earnings calendar and analyst expectations - Upcoming and past events Nasdaq: BNTX Nasdaq hill \u0026 usher photography insurance https://reprogramarteketofit.com

New Report Predicts Significant Growth in mRNA Vaccines

WebJul 27, 2024 · AC Immune SA (NASDAQ: ACIU) has gained a multi-million investment from the principal backers of BioNTech SE (NASDAQ: BNTX) while acquiring a possible Parkinson's disease vaccine. WebMay 9, 2024 · BioNTech's first-quarter sales and earnings more than tripled thanks to demand for the COVID-19 vaccine it developed with Pfizer , but the German biotech firm … WebJun 5, 2024 · Calendars. Trending Tickers. Stocks: Most Actives. Stocks: Gainers. Stocks: Losers. Top ETFs. ... E-mail: [email protected]. Media Relations Jasmina Alatovic VP Corporate Communications Tel ... smart agriculture technology影响因子

What 12 Analyst Ratings Have To Say About BioNTech

Category:BioNTech Announces First Quarter Financial 2024 Results and

Tags:Biontech investor calendar

Biontech investor calendar

What 12 Analyst Ratings Have To Say About BioNTech

WebSep 18, 2024 · In other words, as many stocks worldwide were hitting 52-week low in mid-March, BioNTech investors were jubilant. Yet in a matter of weeks, the shares were …

Biontech investor calendar

Did you know?

WebApr 7, 2024 · Economic Calendar; Earnings; IPO Calendar; Dividend Calendar; ... The projected annual revenue for BioNTech SE is $9,869MM, a decrease of 42.99%. ... data-driven investors. With coverage of over ... Web1 day ago · The global mRNA Vaccines & Therapeutics market size was valued at USD 40960.0 million in 2024 and is expected to expand at a CAGR of -31.55% during the …

WebApr 29, 2024 · BioNTech Media Relations Jasmina Alatovic Senior Manager Global External Communications Tel: +49 (0)6131 9084 7640 or +49 (0)151 1978 1385 E-mail: [email protected] BioNTech Investor Relations WebMar 27, 2024 · BioNTech earned 9.26 euros a share on 4.28 billion euros in sales. That comes out to about $9.97 and $4.61 billion, respectively. Both metrics topped BNTX …

WebBioNTech is a biopharmaceutical company pioneering the development of individualized therapies for cancer and other diseases. ... 422 Number of Organizations • $74.6B Total Funding Amount • 501 Number of Investors. Track . Europe Public Companies . 6,401 Number of Organizations • $342.3B Total Funding Amount • 3,941 Number of Investors. WebNov 13, 2024 · All information in this press release is as of the date of the release, and BioNTech undertakes no duty to update this information unless required by law. CONTACTS. Media Relations Jasmina Alatovic +49 (0)6131 9084 1513 [email protected]. Investor Relations Sylke Maas, PhD. +49 (0)6131 9084 1074 …

WebMar 18, 2024 · For their portion of the partnership, Fosun paid $50 million to purchase 1.58 million BioNTech shares, and will provide $85 million for development and commercialization fees.

WebApr 10, 2024 · 0. 0. In the last 3 months, 12 analysts have offered 12-month price targets for BioNTech. The company has an average price target of $169.33 with a high of $216.00 and a low of $128.00. Below is a ... hill \u0026 wilkinson austinWebMar 23, 2024 · Every investor in BioNTech SE (NASDAQ:BNTX) should be aware of the most powerful shareholder groups. We can see that private equity firms own the lion's share in the company with 43% ownership. hill \u0026 usher insuranceWebApr 7, 2024 · Economic Calendar; Earnings; IPO Calendar; Dividend Calendar; ... The projected annual revenue for BioNTech SE is $9,869MM, a decrease of 42.99%. ... data … smart agriculture irrigation systemWebNov 7, 2024 · BioNTech invites investors and the general public to join a conference call and webcast with investment analysts on November 7, 2024 at 8.00 a.m. EDT (2.00 p.m. CEST) to report its financial results and provide a corporate update for the third quarter of 2024. To access the live conference call via telephone, please register via this link. smart ahorroWebInvestors. Investors Overview Information for stockholders Why Invest Why to join us in our mission Events & Presentations Calendar of upcoming events Financial Reports Quarterly reports and more Investor News ... Emergency uses of Pfizer-BioNTech COVID-19 Vaccine and Pfizer-BioNTech COVID-19 Vaccine, Bivalent have not been approved … smart agtechWebIn October 2024, together with other investors including billionaire twins Thomas and Andreas Strüngmann, MIG led BioNTech’s initial public offering on Nasdaq, which … smart agriculture using raspberry piWebMar 13, 2024 · 02.28.2024. Pfizer Receives Positive FDA Advisory Committee Votes Supporting Potential Approval for Vaccine Candidate to Help Combat RSV in Older … smart agriculture using lora technology